Evaluation of TruVivo®, an All-Human Hepatocyte Model, for Mechanistic DMPK Investigations
June 20, 2023 11 AM EST
Diane Ramsden, PhD, Director of Oncology DMPK at AstraZeneca, presents data from her evaluation of TruVivo as a potential tool for investigating mechanistic drug metabolism and pharmacokinetics, including drug-drug interaction potential and translational risk assessment.